Hospital-Acquired Infections Workup

  • Author: Ayesha Mirza, MD; Chief Editor: Russell W Steele, MD   more...
 
Updated: Jan 5, 2012
 

Laboratory Studies

Laboratory investigations should be guided by the results of a detailed physical examination and review of systems.

Caution should be taken when interpreting laboratory results because not all bacterial or fungal growth on a culture are pathogenic. Growth on cultures may reflect simple microbial colonization. Consider the following:

  • Clinical presentation of the patient
  • Reason for obtaining the test
  • The process by which the specimen was obtained (eg, a urine culture obtained through a newly placed Foley catheter is less likely to be contaminated by microbial colonization)
  • The presence of other supporting evidence of infection (eg, the significance of bacterial growth on tracheal aspirate culture is strengthened by the presence of radiographic changes and clinical signs compatible with pneumonia)

By the same token, known "contaminant" skin organisms such as coagulase-negative staphylococcus, viridans streptococcus, Micrococcus, Corynebacterium, Propionibacterium, and Bacillus species should not easily be dismissed as contaminants if they grew on cultures of normally sterile body fluids (eg, blood, joint fluid, cerebrospinal fluid [CSF]), especially if the patient was at high risk for severe infections (eg, immunocompromised, neonates). Repeating cultures may help establish presence or absence of infection. Fungal growth on a blood culture should never be dismissed as "contamination."

Bloodstream infections

Among the different methods used to establish the catheter as the source of bloodstream infections (catheter-associated bloodstream infection), the differential time to positivity of paired blood cultures is the simplest.[24] The catheter is confirmed as the source of bloodstream infection if the blood culture from the catheter showed microbial growth 2 hours or more earlier than a peripheral blood culture obtained at the same time. The other methods include quantitative cultures of blood obtained from the catheter and peripheral vein and also, quantitative culture of catheter segment. Unfortunately, quantitative culture is not readily available in most laboratories and culture of the catheter requires pulling out the device.

Multiple blood cultures over 24 hours and appropriate volume of blood sample may increase the yield in cases of intermittent or low-inoculum bacteremia. Fungal cultures should be obtained if fungal infection is suspected. The laboratory should incubate cultures longer for fungus detection than for other pathogens.

Imaging studies such as echocardiography should be considered if thrombosis or vegetations is a concern. Candidate patients include those who have prolonged or persistent bacteremia or fungemia despite antimicrobial therapy or in patients with a new-onset murmur.

In immunocompromised patients, special studies are occasionally requested, such as cultures for nocardia and atypical mycobacteria, cytomegalovirus, and cytomegalovirus antigenemia detection.

Pneumonia

Acute phase reactants (peripheral WBC count, erythrocyte sedimentation rate, C-reactive protein) may be elevated but are not specific in distinguishing bacterial from viral pneumonia.

Decreasing oxygen saturation and worsening hemodynamic status are clues to the presence of pneumonia.

The presence of a new infiltrate on chest radiograph is supporting evidence of pneumonia; however, it may sometimes be difficult to differentiate from atelectasis.

Sputum gram stain and cultures may be useful. However, especially in the case of young children unable to effectively cough up phlegm, sputum samples maybe contaminated by saliva and upper respiratory tract organisms. An acceptable sample should have less than 10 squamous epithelial cells, more than 25 neutrophils per low-power field and culture growing a predominant organism.

As in the case of sputum samples, materials obtained via suctioning of endotracheal, nasotracheal, and tracheostomy tubes may not be reliable because these may be contaminated by upper respiratory tract organisms. Other methods to obtain specimens for microbiologic evaluation include bronchoalveolar lavage and thoracentesis.

Efforts to distinguish tracheobronchial colonization, ventilator-associated tracheobronchitis, and ventilator-associated pneumonia may help avoid inappropriate antibiotic use.[25]

Rapid diagnostic tests may be valuable in specific cases. Examples include the direct fluorescent antibody test for Legionella organisms; polymerase chain reaction tests for Bordetella pertussis; immunofluorescence tests for influenza, respiratory syncytial virus, and Pneumocystis jiroveci; and modified acid-fast stains for mycobacteria.

Urinary tract infection

Urinalysis and urine culture along with clinical findings are essential in differentiating asymptomatic bacteriuria, cystitis and pyelonephritis. The presence of pyuria, bacteria, nitrites and leukocyte esterase on urinalysis makes urinary tract infection likely.

Urinary tract infection is highly likely when the urine culture (obtained by transurethral catheterization) is growing more than 100,000 colony-forming units/mL of a single organism. Urine culture interpretation should be taken with caution as this may lead to overdiagnosis and subsequent unnecessary evaluation and treatment. The following factors should be kept in mind when interpreting urine cultures:

  • Number of colonies and species isolated
  • Method of sample collection
  • Time from collection to laboratory processing
  • Sex of the patient
  • Previous antibiotic use

Although imaging studies are controversial, they are recommended by most experts in evaluating children with first-time urinary tract infection. Renal ultrasonography and voiding cystourethrography are the 2 most commonly used modalities to evaluate for anatomical abnormalities. Renal ultrasonography may also help detect abscesses or phlegmons in patients unresponsive to antibiotic therapy.

Other healthcare-associated infections

Cultures of specimen from the surgical site infection may reveal pathogens and help tailor antibiotic therapy.

Detection of rotavirus antigen in stool confirms gastroenteritis due to rotavirus.

Available tests to detect Clostridium difficile include stool culture, enzyme immunoassay for toxin detection, and polymerase chain reaction tests.

Next

Imaging Studies

Special imaging techniques (eg, ultrasonography, CT scan, MRI) may be helpful in evaluating obscure-site infections.

Previous
 
 
Contributor Information and Disclosures
Author

Ayesha Mirza, MD  Assistant Professor, Pediatric Infectious Diseases, University of Florida College of Medicine Jacksonville

Ayesha Mirza, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Tropical Medicine and Hygiene, HIV Medicine Association of America, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Coauthor(s)

Haidee T Custodio, MD  Assistant Professor, Department of Pediatrics, Division of Pediatric Infectious Diseases, University of South Alabama College of Medicine

Haidee T Custodio, MD is a member of the following medical societies: American Academy of Pediatrics, Infectious Diseases Society of America, and Pediatric Infectious Diseases Society

Disclosure: Nothing to disclose.

Specialty Editor Board

David Jaimovich, MD  Chief Medical Officer, Joint Commission International and Joint Commission Resources

David Jaimovich, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Joseph Domachowske, MD  Professor of Pediatrics, Microbiology and Immunology, Department of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical University

Joseph Domachowske, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Society for Microbiology, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Robert W Tolan Jr, MD  Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine

Robert W Tolan Jr, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, Phi Beta Kappa, and Physicians for Social Responsibility

Disclosure: Novartis Honoraria Speaking and teaching

Chief Editor

Russell W Steele, MD  Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine

Russell W Steele, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American Pediatric Society, American Society for Microbiology, Infectious Diseases Society of America, Louisiana State Medical Society, Pediatric Infectious Diseases Society, Society for Pediatric Research, and Southern Medical Association

Disclosure: Nothing to disclose.

References
  1. Coffin SE, Zaoutis TE. Healthcare-Associated Infections. In: Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Churchill Livingstone; 2008:chap 101.

  2. Hospital Infections Program, National Center for Infectious Diseases, CDC. Public Health Focus: surveillance, prevention, and control of nosocomial infections. MMWR. October 1992;41(42):783-787.

  3. Hughes JM. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. Chemotherapy. 1988;34(6):553-61. [Medline].

  4. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control. Nov 2008;36(9):609-26. [Medline].

  5. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. Mar-Apr 2001;7(2):174-7. [Medline].

  6. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr. Apr 2002;140(4):432-8. [Medline].

  7. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, Grohskopf LA, Levine GL, Stover BH. Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey. J Pediatr. Dec 2001;139(6):821-7. [Medline].

  8. Tikhomirov E. WHO programme for the control of hospital infections. Chemioterapia. June 1987;6(3):148-51.

  9. Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control. Nov 2008;36(9):627-37. [Medline].

  10. Aiken AM, Mturi N, Njuguna P, Mohammed S, Berkley JA, Mwangi I, et al. Risk and causes of paediatric hospital-acquired bacteraemia in Kilifi District Hospital, Kenya: a prospective cohort study. Lancet. Dec 10 2011;378(9808):2021-7. [Medline].

  11. Gastmeier P, Geffers C, Brandt C, Zuschneid I, Sohr D, Schwab F. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. Sep 2006;64(1):16-22. [Medline].

  12. Klevens RM, Edwards JR, Richards CL, et al. Estimating healthcare-associated infections in US hospitals, 2002. Public Health Rep. Mar 2007;122(2):160-6.

  13. Scott RD. The direct medical costs of healthcare-associated infections in US hospitals and the benefits of prevention, 2008. CDC. Available at http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf. Accessed 7/1/2009.

  14. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. Mar 4 2011;60(8):243-8. [Medline].

  15. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics. Apr 1999;103(4):e39. [Medline].

  16. Mahieu LM, De Muynck AO, Ieven MM, De Dooy JJ, Goossens HJ, Van Reempts PJ. Risk factors for central vascular catheter-associated bloodstream infections among patients in a neonatal intensive care unit. J Hosp Infect. Jun 2001;48(2):108-16. [Medline].

  17. Newman CD. Catheter-related bloodstream infections in the pediatric intensive care unit. Semin Pediatr Infect Dis. Jan 2006;17(1):20-4. [Medline].

  18. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. Apr 2000;19(4):319-24. [Medline].

  19. Elward AM, Warren DK, Fraser VJ. Ventilator-associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics. May 2002;109(5):758-64. [Medline].

  20. Fayon MJ, Tucci M, Lacroix J, et al. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. Am J Respir Crit Care Med. Jan 1997;155(1):162-9. [Medline].

  21. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics. Dec 2003;112(6 Pt 1):1283-9. [Medline].

  22. Moulin F, Quintart A, Sauvestre C, Mensah K, Bergeret M, Raymond J. [Nosocomial urinary tract infections: retrospective study in a pediatric hospital]. Arch Pediatr. 1998;5 Suppl 3:274S-278S. [Medline].

  23. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. Jun 2008;36(5):309-32. [Medline].

  24. Zaoutis TE, Coffin SE. Clinical Syndromes of Device-Associated Infections. In: Long SS, Pickering LK, Prober CG. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Churchill Livingstone; 2008:chap 102.

  25. Craven DE, Chroneou A, Zias N, Hjalmarson KI. Ventilator-associated tracheobronchitis: the impact of targeted antibiotic therapy on patient outcomes. Chest. Feb 2009;135(2):521-8. [Medline].

  26. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. Feb 15 2005;171(4):388-416. [Medline].

  27. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. Nov 19 2003;290(19):2588-98. [Medline].

  28. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. CDC. Available at http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Isolation2007.pdf. Accessed 7/9/2009.

  29. Committee on Infectious Diseases, American Academy of Pediatrics. Pickering LK. Red Book 2006. 27th ed. American Academy of Pediatrics; 2006:153-160.

  30. Guidelines for the prevention of intravascular catheter-related infections. CDC. Available at http://www.cdc.gov/mmwr/PDF/rr/rr5110.pdf. Accessed 7/7/2009.

  31. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. Mar 26 2004;53:1-36. [Medline].

  32. Wong ES, Hooton TM. Guideline for prevention of catheter-associated urinary tract infections. CDC. Available at http://www.cdc.gov/ncidod/dhqp/gl_catheter_assoc.html. Accessed 7/7/2009.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.